Cascadian Therapeutics (CASC) Sees Upside on Puma Biotech (PBYI) Stumble

November 14, 2016 10:57 AM EST

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Cascadian Therapeutics (NASDAQ: CASC) gaining related to the plunge in Puma Biotech (NYSE: PBYI).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment